Inter-relationships between single carbon units' metabolism and resting energy expenditure in weight-losing patients with small cell lung cancer. Effects of methionine supply and chemotherapy.
The one-carbon unit metabolism was investigated in 8 weight-losing patients with small cell carcinoma of the lung (SCLC). At diagnosis, 6 of the 8 patients had elevated formiminoglutamic acid (FIGLU) excretion after a histidine load, suggesting a lack of one-carbon units. In accordance, a significant decrease of FIGLU excretion was observed in the patients after oral administration of DL-methionine for 4 days. The elevated FIGLU excretion was positively correlated to weight loss prior to diagnosis and negatively correlated to serum albumin at time of diagnosis. After 3 months of combination chemotherapy, FIGLU excretion was reduced in all patients except 1, who had progressive disease. Despite the elevated FIGLU excretions, all patients had normal blood folate levels. The resting energy expenditure (REE) was recorded in 7 patients, and a significant, positive correlation was observed between pretreatment FIGLU excretion and REE, although the REE measured in this group of patients was within the normal range. These data demonstrate an increased demand of "active" one-carbon units in energy consumption in a group of weight-losing cancer patients. The one-carbon unit deficit was reconditioned by oral administration of the one-carbon unit donor DL-methionine.
Sengeløv
H
H
Department of Medicine, Bispebjerg Hospital, Copenhagen, Denmark.
Hansen
O P
OP
Simonsen
L
L
Bülow
J
J
Nielsen
O J
OJ
Ovesen
L
L
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001481:Basal Metabolism / Q000502:physiology*; D002100:Cachexia / Q000209:etiology / Q000378:metabolism*; D002244:Carbon / Q000378:metabolism*; D018288:Carcinoma, Small Cell / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D005565:Formiminoglutamic Acid / Q000652:urine; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D008715:Methionine / Q000494:pharmacology; D008875:Middle Aged
D002244:Carbon; D005565:Formiminoglutamic Acid; D008715:Methionine